Heart Failure Treatment Market by Type andApplication- Global Industry Analysis & Forecast to 2027
Published On : November 2020 Pages : 154 Category: Pharma & Healthcare Report Code : HC1113668
Heart Failure TreatmentMarket by Type(VADs,ICDs,Drugs, Others)Application (Clinic,Hospital,Household,Others)- Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
Heart Failure TreatmentMarket has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period.Heart failure is a physiological condition that adversely affects the pumping effectiveness of the heart muscles. It describes the aggregation of liquid around the heart prompting wasteful pumping. The beginning of a heart failure is set apart by the disappointment of the ventricles to siphon adequate volume of blood to the body organs.
Drivers and Restraints
Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Regional Insights
The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- SouthAmerica
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- Abbott
- Merck
- New Haven Pharmaceuticals, Inc.
- HeartWare
- GlaxoSmithKline plc
- Biovail Corporation
- Medtronic
- Johnson & Johnson
- Stanley Pharmaceuticals
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2021 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Heart Failure Treatment Market, ByType, Estimates and Forecast, 2017-2027 ($Million)
o VADs
o ICDs
o Drugs
o Others
· Heart Failure Treatment Market, ByApplication, Estimates and Forecast, 2017-2027 ($Million)
o Clinic
o Hospital
o Household
· Heart Failure Treatment Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o Abbott
o Merck
o New Haven Pharmaceuticals, Inc.
o HeartWare
o GlaxoSmithKline plc
o Biovail Corporation
o Medtronic
o Johnson & Johnson
o Stanley Pharmaceuticals
· Heart Failure Treatment Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Heart Failure Treatment Market, By Country
o U.S. Heart Failure Treatment Market
o Canada Heart Failure Treatment Market
o Mexico Heart Failure Treatment Market
o Europe
§ Europe Heart Failure Treatment Market, By Country
· Germany Heart Failure Treatment Market
o UK Heart Failure Treatment Market
o France Heart Failure Treatment Market
o RussiaHeart Failure Treatment Market
o Italy Heart Failure Treatment Market
o Rest of Europe Heart Failure Treatment Market
o Asia-Pacific
§ Asia-Pacific Heart Failure Treatment Market, By Country
o ChinaHeart Failure Treatment Market
o Japan Heart Failure Treatment Market
o South KoreaHeart Failure Treatment Market
o India Heart Failure Treatment Market
o Southeast AsiaHeart Failure Treatment Market
o Rest of Asia-Pacific Heart Failure Treatment Market
o South America
§ South AmericaHeart Failure Treatment Market
o Brazil Heart Failure Treatment Market
o ArgentinaHeart Failure Treatment Market
o ColumbiaHeart Failure Treatment Market
o Rest of South America Heart Failure Treatment Market
o Middle East and Africa
§ Middle East and AfricaHeart Failure Treatment Market
o Saudi ArabiaHeart Failure Treatment Market
o UAEHeart Failure Treatment Market
o EgyptHeart Failure Treatment Market
o NigeriaHeart Failure Treatment Market
o South Africa Heart Failure Treatment Market
o Rest of MEA Heart Failure Treatment Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Heart Failure Treatment Market, By Type
5.1. Introduction
5.2. Global Heart Failure Treatment Revenue and Market Share by Type (2017-2021)
5.2.1. Global Heart Failure Treatment Revenue and Revenue Share by Type (2017-2021)
5.3. VADs
5.3.1. Global VADs Revenue and Growth Rate (2017-2021)
5.4. ICDs
5.4.1. Global ICDs Revenue and Growth Rate (2017-2021)
5.5. Drugs
5.5.1. Global Drugs Revenue and Growth Rate (2017-2021)
5.6. Others
5.6.1. Global Others Revenue and Growth Rate (2017-2021)
6. Heart Failure Treatment Market, By Application
6.1. Introduction
6.2. Global Heart Failure Treatment Revenue and Market Share by Application (2017-2021)
6.2.1. Global Heart Failure Treatment Revenue and Revenue Share by Application (2017-2021)
6.3. Clinic
6.3.1. Global Clinic Revenue and Growth Rate (2017-2021)
6.4. Hospital
6.4.1. Global Hospital Revenue and Growth Rate (2017-2021)
6.5. Household
6.5.1. Global Household Revenue and Growth Rate (2017-2021)
6.6. Others
6.6.1. Global Others Revenue and Growth Rate (2017-2021)
7. Heart Failure Treatment Market, By Region
7.1. Introduction
7.2. Global Heart Failure Treatment Revenue and Market Share by Regions
7.2.1. Global Heart Failure Treatment Revenue by Regions (2017-2021)
7.3. North America Heart Failure Treatment by Countries
7.3.1. North America Heart Failure Treatment Revenue and Growth Rate (2017-2021)
7.3.2. North America Heart Failure Treatment Revenue (Million USD) by Countries (2017-2021)
7.3.3. United States
7.3.3.1. United States Heart Failure Treatment Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.4. Canada
7.3.4.1. Canada Heart Failure Treatment Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.5. Mexico
7.3.5.1. Mexico Heart Failure Treatment Revenue (Millions USD) and Growth Rate (2017-2021)
7.4. Europe Heart Failure Treatment by Countries
7.4.1. Europe Heart Failure Treatment Revenue and Growth Rate (2017-2021)
7.4.2. Europe Heart Failure Treatment Revenue (Million USD) by Countries (2017-2021)
7.4.3. Germany
7.4.3.1. Germany Heart Failure Treatment Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.4. France
7.4.4.1. France Heart Failure Treatment Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.5. UK
7.4.5.1. UK Heart Failure Treatment Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.6. Russia
7.4.6.1. Russia Heart Failure Treatment Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.7. Italy
7.4.7.1. Italy Heart Failure Treatment Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Heart Failure Treatment Revenue (Millions USD) and Growth Rate (2017-2021)
7.5. Asia-Pacific Heart Failure Treatment by Countries
7.5.1. Asia-Pacific Heart Failure Treatment Revenue and Growth Rate (2017-2021)
7.5.2. Asia-Pacific Heart Failure Treatment Revenue (Million USD) by Countries (2017-2021)
7.5.3. China
7.5.3.1. China Heart Failure Treatment Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.4. Japan
7.5.4.1. Japan Heart Failure Treatment Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.5. Korea
7.5.5.1. Korea Heart Failure Treatment Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.6. India
7.5.6.1. India Heart Failure Treatment Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Heart Failure Treatment Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Heart Failure Treatment Revenue (Millions USD) and Growth Rate (2017-2021)
7.6. South America Heart Failure Treatment by Countries
7.6.1. South America Heart Failure Treatment Revenue and Growth Rate (2017-2021)
7.6.2. South America Heart Failure Treatment Revenue (Million USD) by Countries (2017-2021)
7.6.3. Brazil
7.6.3.1. Brazil Heart Failure Treatment Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.4. Argentina
7.6.4.1. Argentina Heart Failure Treatment Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.5. Columbia
7.6.5.1. Columbia Heart Failure Treatment Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Heart Failure Treatment Revenue (Millions USD) and Growth Rate (2017-2021)
7.7. Middle East and Africa Heart Failure Treatment by Countries
7.7.1. Middle East and Africa Heart Failure Treatment Revenue and Growth Rate (2017-2021)
7.7.2. Middle East and Africa Heart Failure Treatment Revenue (Million USD) by Countries (2017-2021)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Heart Failure Treatment Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Heart Failure Treatment Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.5. Egypt
7.7.5.1. Egypt Heart Failure Treatment Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.6. Nigeria
7.7.6.1. Nigeria Heart Failure Treatment Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.7. South Africa
7.7.7.1. South Africa Heart Failure Treatment Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.8. Turkey
7.7.8.1. Turkey Heart Failure Treatment Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Heart Failure Treatment Revenue (Millions USD) and Growth Rate (2017-2021)
8. Company Profiles
8.1. Abbott
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. Merck
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. New Haven Pharmaceuticals, Inc.
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. HeartWare
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. GlaxoSmithKline plc
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
8.6. Biovail Corporation
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Financial Overview
8.7. Medtronic
8.7.1. Business Overview
8.7.2. Service Portfolio
8.7.3. Strategic Developments
8.7.4. Financial Overview
8.8. Johnson & Johnson
8.8.1. Business Overview
8.8.2. Service Portfolio
8.8.3. Strategic Developments
8.8.4. Financial Overview
8.9. Stanley Pharmaceuticals
8.9.1. Business Overview
8.9.2. Service Portfolio
8.9.3. Strategic Developments
8.9.4. Financial Overview
9. Heart Failure Treatment Market Forecast (2022-2027)
9.1. Global Heart Failure Treatment Revenue (Millions USD) and Growth Rate (2022-2027)
9.2. Heart Failure Treatment Market Forecast by Regions (2022-2027)
9.2.1. North America Heart Failure Treatment Market Forecast (2022-2027)
9.2.1.1. United States Heart Failure Treatment Market Forecast (2022-2027)
9.2.1.2. Canada Heart Failure Treatment Market Forecast (2022-2027)
9.2.1.3. Mexico Heart Failure Treatment Market Forecast (2022-2027)
9.2.2. Europe Heart Failure Treatment Market Forecast (2022-2027)
9.2.2.1. Germany Heart Failure Treatment Market Forecast (2022-2027)
9.2.2.2. France Heart Failure Treatment Market Forecast (2022-2027)
9.2.2.3. UK Heart Failure Treatment Market Forecast (2022-2027)
9.2.2.4. Russia Heart Failure Treatment Market Forecast (2022-2027)
9.2.2.5. Italy Heart Failure Treatment Market Forecast (2022-2027)
9.2.2.6. Rest of Europe Heart Failure Treatment Market Forecast (2022-2027)
9.2.3. Asia-Pacific Heart Failure Treatment Market Forecast (2022-2027)
9.2.3.1. China Heart Failure Treatment Market Forecast (2022-2027)
9.2.3.2. Japan Heart Failure Treatment Market Forecast (2022-2027)
9.2.3.3. Korea Heart Failure Treatment Market Forecast (2022-2027)
9.2.3.4. India Heart Failure Treatment Market Forecast (2022-2027)
9.2.3.5. Southeast Asia Heart Failure Treatment Market Forecast (2022-2027)
9.2.3.6. Rest of Asia-Pacific Heart Failure Treatment Market Forecast (2022-2027)
9.2.4. South America Heart Failure Treatment Market Forecast (2022-2027)
9.2.4.1. Brazil Heart Failure Treatment Market Forecast (2022-2027)
9.2.4.2. Argentina Heart Failure Treatment Market Forecast (2022-2027)
9.2.4.3. Columbia Heart Failure Treatment Market Forecast (2022-2027)
9.2.4.4. Rest of South America Heart Failure Treatment Market Forecast (2022-2027)
9.2.5. Middle East and Africa Heart Failure Treatment Market Forecast (2022-2027)
9.2.5.1. Saudi Arabia Heart Failure Treatment Market Forecast (2022-2027)
9.2.5.2. United Arab Emirates Heart Failure Treatment Market Forecast (2022-2027)
9.2.5.3. Egypt Heart Failure Treatment Market Forecast (2022-2027)
9.2.5.4. Nigeria Heart Failure Treatment Market Forecast (2022-2027)
9.2.5.5. South Africa Heart Failure Treatment Market Forecast (2022-2027)
9.2.5.6. Turkey Heart Failure Treatment Market Forecast (2022-2027)
9.2.5.7. Rest of Middle East and Africa Heart Failure Treatment Market Forecast (2022-2027)
9.3. Heart Failure Treatment Market Forecast by Type (2022-2027)
9.3.1. Heart Failure Treatment Forecast by Type (2022-2027)
9.3.2. Heart Failure Treatment Market Share Forecast by Type (2022-2027)
9.4. Heart Failure Treatment Market Forecast by Application (2022-2027)
9.4.1. Heart Failure Treatment Forecast by Application (2022-2027)
9.4.2. Heart Failure Treatment Market Share Forecast by Application (2022-2027)
List of Tables
List of Tables and Figures:
Figure United States Heart Failure Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure Canada Heart Failure Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure Mexico Heart Failure Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure Germany Heart Failure Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure France Heart Failure Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure UK Heart Failure Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure Russia Heart Failure Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure Italy Heart Failure Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Europe Heart Failure Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Heart Failure Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Heart Failure Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure Korea Heart Failure Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Heart Failure Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Heart Failure Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Asia-Pacific Heart Failure Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure Brazil Heart Failure Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure Argentina Heart Failure Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure Columbia Heart Failure Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of South America Heart Failure Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure Saudi Arabia Heart Failure Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure United Arab Emirates Heart Failure Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure Egypt Heart Failure Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure Nigeria Heart Failure Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure South Africa Heart Failure Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure Turkey Heart Failure Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Middle East and Africa Heart Failure Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Table Global Heart Failure Treatment Revenue and Revenue Share by Type (2017-2019)
Figure Global VADs Revenue and Growth Rate (2017-2019)
Figure Global ICDs Revenue and Growth Rate (2017-2019)
Figure Global Drugs Revenue and Growth Rate (2017-2019)
Figure Global Others Revenue and Growth Rate (2017-2019)
Table Global Heart Failure Treatment Revenue and Revenue Share by Application (2017-2019)
Figure Global Clinic Revenue and Growth Rate (2017-2019)
Figure Global Hospital Revenue and Growth Rate (2017-2019)
Figure Global Household Revenue and Growth Rate (2017-2019)
Figure Global Others Revenue and Growth Rate (2017-2019)
Table Global Heart Failure Treatment Revenue by Regions (2017-2019)
Figure North America Heart Failure Treatment Growth Rate (2017-2019)
Figure North America Heart Failure Treatment Revenue and Growth Rate (2017-2019)
Figure North America Heart Failure Treatment by Countries (2017-2019)
Figure North America Heart Failure Treatment Revenue (Million USD) by Countries (2017-2019)
Figure United States Heart Failure Treatment Growth Rate (2017-2019)
Figure United States Heart Failure Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Canada Heart Failure Treatment Growth Rate (2017-2019)
Figure Canada Heart Failure Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Mexico Heart Failure Treatment Growth Rate (2017-2019)
Figure Mexico Heart Failure Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Europe Heart Failure Treatment Growth Rate (2017-2019)
Figure Europe Heart Failure Treatment Revenue and Growth Rate (2017-2019)
Figure Europe Heart Failure Treatment by Countries (2017-2019)
Figure Europe Heart Failure Treatment Revenue (Million USD) by Countries (2017-2019)
Figure Germany Heart Failure Treatment Growth Rate (2017-2019)
Figure Germany Heart Failure Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure France Heart Failure Treatment Growth Rate (2017-2019)
Figure France Heart Failure Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure UK Heart Failure Treatment Growth Rate (2017-2019)
Figure UK Heart Failure Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Russia Heart Failure Treatment Growth Rate (2017-2019)
Figure Russia Heart Failure Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Italy Heart Failure Treatment Growth Rate (2017-2019)
Figure Italy Heart Failure Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Europe Heart Failure Treatment Growth Rate (2017-2019)
Figure Rest of Europe Heart Failure Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Asia-Pacific Heart Failure Treatment Growth Rate (2017-2019)
Figure Asia-Pacific Heart Failure Treatment Revenue and Growth Rate (2017-2019)
Figure Asia-Pacific Heart Failure Treatment by Countries (2017-2019)
Figure Asia-Pacific Heart Failure Treatment Revenue (Million USD) by Countries (2017-2019)
Figure China Heart Failure Treatment Growth Rate (2017-2019)
Figure China Heart Failure Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Japan Heart Failure Treatment Growth Rate (2017-2019)
Figure Japan Heart Failure Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Korea Heart Failure Treatment Growth Rate (2017-2019)
Figure Korea Heart Failure Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure India Heart Failure Treatment Growth Rate (2017-2019)
Figure India Heart Failure Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Southeast Asia Heart Failure Treatment Growth Rate (2017-2019)
Figure Southeast Asia Heart Failure Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Heart Failure Treatment Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Heart Failure Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South America Heart Failure Treatment Growth Rate (2017-2019)
Figure South America Heart Failure Treatment Revenue and Growth Rate (2017-2019)
Figure South America Heart Failure Treatment by Countries (2017-2019)
Figure South America Heart Failure Treatment Revenue (Million USD) by Countries (2017-2019)
Figure Brazil Heart Failure Treatment Growth Rate (2017-2019)
Figure Brazil Heart Failure Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Argentina Heart Failure Treatment Growth Rate (2017-2019)
Figure Argentina Heart Failure Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Columbia Heart Failure Treatment Growth Rate (2017-2019)
Figure Columbia Heart Failure Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of South America Heart Failure Treatment Growth Rate (2017-2019)
Figure Rest of South America Heart Failure Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Middle East and Africa Heart Failure Treatment Growth Rate (2017-2019)
Figure Middle East and Africa Heart Failure Treatment Revenue and Growth Rate (2017-2019)
Figure Middle East and Africa Heart Failure Treatment by Countries (2017-2019)
Figure Middle East and Africa Heart Failure Treatment Revenue (Million USD) by Countries (2017-2019)
Figure Saudi Arabia Heart Failure Treatment Growth Rate (2017-2019)
Figure Saudi Arabia Heart Failure Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure United Arab Emirates Heart Failure Treatment Growth Rate (2017-2019)
Figure United Arab Emirates Heart Failure Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Egypt Heart Failure Treatment Growth Rate (2017-2019)
Figure Egypt Heart Failure Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Nigeria Heart Failure Treatment Growth Rate (2017-2019)
Figure Nigeria Heart Failure Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South Africa Heart Failure Treatment Growth Rate (2017-2019)
Figure South Africa Heart Failure Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Turkey Heart Failure Treatment Growth Rate (2017-2019)
Figure Turkey Heart Failure Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Heart Failure Treatment Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Heart Failure Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Table Abbott Heart Failure Treatment Financial Overview
Table Merck Heart Failure Treatment Financial Overview
Table New Haven Pharmaceuticals, Inc. Heart Failure Treatment Financial Overview
Table HeartWare Heart Failure Treatment Financial Overview
Table GlaxoSmithKline plc Heart Failure Treatment Financial Overview
Table Biovail Corporation Heart Failure Treatment Financial Overview
Table Medtronic Heart Failure Treatment Financial Overview
Table Johnson & Johnson Heart Failure Treatment Financial Overview
Table Stanley Pharmaceuticals Heart Failure Treatment Financial Overview
Figure Global Heart Failure Treatment Revenue (Millions USD) and Growth Rate (2019-2027)
Table Heart Failure Treatment Market Forecast by Regions (2019-2027)
Figure North America Heart Failure Treatment Market Forecast (2019-2027)
Figure United States Heart Failure Treatment Market Forecast (2019-2027)
Figure Canada Heart Failure Treatment Market Forecast (2019-2027)
Figure Mexico Heart Failure Treatment Market Forecast (2019-2027)
Figure Europe Heart Failure Treatment Market Forecast (2019-2027)
Figure Germany Heart Failure Treatment Market Forecast (2019-2027)
Figure France Heart Failure Treatment Market Forecast (2019-2027)
Figure UK Heart Failure Treatment Market Forecast (2019-2027)
Figure Russia Heart Failure Treatment Market Forecast (2019-2027)
Figure Italy Heart Failure Treatment Market Forecast (2019-2027)
Figure Rest of Europe Heart Failure Treatment Market Forecast (2019-2027)
Figure Asia-Pacific Heart Failure Treatment Market Forecast (2019-2027)
Figure China Heart Failure Treatment Market Forecast (2019-2027)
Figure Japan Heart Failure Treatment Market Forecast (2019-2027)
Figure Korea Heart Failure Treatment Market Forecast (2019-2027)
Figure India Heart Failure Treatment Market Forecast (2019-2027)
Figure Southeast Asia Heart Failure Treatment Market Forecast (2019-2027)
Figure Rest of Asia-Pacific Heart Failure Treatment Market Forecast (2019-2027)
Figure South America Heart Failure Treatment Market Forecast (2019-2027)
Figure Brazil Heart Failure Treatment Market Forecast (2019-2027)
Figure Argentina Heart Failure Treatment Market Forecast (2019-2027)
Figure Columbia Heart Failure Treatment Market Forecast (2019-2027)
Figure Rest of South America Heart Failure Treatment Market Forecast (2019-2027)
Figure Middle East and Africa Heart Failure Treatment Market Forecast (2019-2027)
Figure Saudi Arabia Heart Failure Treatment Market Forecast (2019-2027)
Figure United Arab Emirates Heart Failure Treatment Market Forecast (2019-2027)
Figure Egypt Heart Failure Treatment Market Forecast (2019-2027)
Figure Nigeria Heart Failure Treatment Market Forecast (2019-2027)
Figure South Africa Heart Failure Treatment Market Forecast (2019-2027)
Figure Turkey Heart Failure Treatment Market Forecast (2019-2027)
Figure Rest of Middle East and Africa Heart Failure Treatment Market Forecast (2019-2027)
Figure Global Heart Failure Treatment Forecast by Type (2019-2027)
Figure Global Heart Failure Treatment Market Share Forecast by Type (2019-2027)
Figure Global Heart Failure Treatment Forecast by Type (2019-2027)
Figure Global Heart Failure Treatment Forecast by Application (2019-2027)
Figure Global Heart Failure Treatment Market Share Forecast by Application (2019-2027)
Figure Global Heart Failure Treatment Forecast by Application (2019-2027)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|